Literature DB >> 8584339

Intravenous ribavirin therapy for disseminated adenovirus infection.

A J McCarthy1, M Bergin, L M De Silva, M Stevens.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8584339     DOI: 10.1097/00006454-199511000-00017

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  6 in total

1.  Intravenous ribavirin for infant bronchiolitis.

Authors:  A Oommen; D K Luyt; S Nichani
Journal:  J R Soc Med       Date:  1999-02       Impact factor: 5.344

2.  Intestinal absorption of ribavirin is preferentially mediated by the Na+-nucleoside purine (N1) transporter.

Authors:  S D Patil; L Y Ngo; P Glue; J D Unadkat
Journal:  Pharm Res       Date:  1998-06       Impact factor: 4.200

Review 3.  Prevention and treatment recommendations for respiratory syncytial virus infection. Background and clinical experience 40 years after discovery.

Authors:  M G Ottolini; V G Hemming
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

Review 4.  Antiviral therapy: respiratory infections, chronic hepatitis.

Authors:  B I Asmar; N M Abdel-Haq
Journal:  Indian J Pediatr       Date:  2001-07       Impact factor: 5.319

5.  Fatal adenovirus type 7b infection in a child with Smith-Lemli-Opitz syndrome.

Authors:  A Beby-Defaux; L Maille; S Chabot; A Nassimi; D Oriot; G Agius
Journal:  J Med Virol       Date:  2001-09       Impact factor: 2.327

Review 6.  Treatment of respiratory virus infections.

Authors:  Yacine Abed; Guy Boivin
Journal:  Antiviral Res       Date:  2006-02-14       Impact factor: 5.970

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.